Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer

Study Purpose

The purpose of this study is to examine changes in perceived daily performance and executive functioning following chemotherapy in individuals with non-central nervous system cancers.

Recruitment Criteria

Accepts Healthy Volunteers Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms	No
Study Type An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies.	Interventional
Eligible Ages	18 Years - 75 Years
Gender	All

More Inclusion & Exclusion Criteria

Inclusion Criteria:

- Newly diagnosed with a primary non-central nervous system malignancy (lung, breast, colon, ulcer, urinary tract, canine tumors).

- Stages I-III.

- Pre-commencement of adjuvant (post-surgery) or neoadjuvant (prior to surgery) chemotherapy.

- Understand and read Hebrew.

- Have at least 12 years of education.

Exclusion Criteria:

- Diagnosed with central nervous system malignancies.

- Had a previous malignancy.

- Have or had metastatic disease.

- Have a history of a neurological condition or severe depression.

Trial Details

Trial ID: This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.	NCT05599698
Phase Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.	N/A
Lead Sponsor The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.	Bnai Zion Medical Center
Principal Investigator The person who is responsible for the scientific and technical direction of the entire clinical study.	Abed Agbarya, MD
Principal Investigator Affiliation	[email protected]
Agency Class Category of organization(s) involved as sponsor (and collaborator) supporting the trial.	Other
Overall Status	Recruiting
Countries	Israel
Conditions The disease, disorder, syndrome, illness, or injury that is being studied.	Cancer

Arms & Interventions

Arms

Experimental: chemotherapy

chemotherapy

Interventions

Other: - Chemotherapy

Standard chemotherapy protocols for adjuvant & neoadjuvant treatment for different types of solid malignancies

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Bnai Zion Medical Center, Haifa, Israel

Status

Recruiting

Address

Bnai Zion Medical Center

Haifa, ,

Site Contact

Abed Agbarya, MD

[email protected]

+972502062679

Clinical Trial Finder